Industry News
Pharmaceutical Industry News
Acadia slims Nuplazid label expansion bid in hopes of clinching Alzheimer’s dementia nod without extra studies
Acadia slims Nuplazid label expansion bid in hopes of clinching Alzheimer's dementia nod without extra studies fkansteiner Tue, 12/21/2021 - 08:54
Iacta bags rights to Tallc’s pan-ocular drug delivery technology
Iacta bags rights to Tallc's pan-ocular drug delivery technology ntaylor Tue, 12/21/2021 - 08:39
BARDA, in ‘Beyond the Needle’ DRIVe, backs IDRI to develop nasal RNA vaccine against pandemic flu
BARDA, in 'Beyond the Needle' DRIVe, backs IDRI to develop nasal RNA vaccine against pandemic flu ntaylor Tue, 12/21/2021 - 08:35
Candel enlists Bionauts for fight against brain cancers, setting stage for delivery of oncolytic viruses using tiny robots
Candel enlists Bionauts for fight against brain cancers, setting stage for delivery of oncolytic viruses using tiny robots ntaylor Tue, 12/21/2021 - 08:32
Editor’s corner: The top 10 Fierce Pharma Marketing stories of 2021 recapped
Editor's corner: The top 10 Fierce Pharma Marketing stories of 2021 recapped badams Tue, 12/21/2021 - 07:32
Family in Nigeria Lost 3 Daughters to Sickle Cell. Can They Save a Fourth?
About 150,000 babies are born each year in Nigeria with sickle cell, a deadly disease. Tens of thousands of them die annually before their fifth birthdays.
Novartis wins belated Leqvio FDA approval, with a plan to avoid the pitfalls of earlier PCSK9 cholesterol drugs
Novartis wins belated Leqvio FDA approval, with a plan to avoid the pitfalls of earlier PCSK9 cholesterol drugs aliu Tue, 12/21/2021 - 05:48
Novartis aims to avoid pitfalls of earlier PCSK9 launches with its new blockbuster hopeful Leqvio
Novartis aims to avoid pitfalls of earlier PCSK9 launches with its new blockbuster hopeful Leqvio aliu Tue, 12/21/2021 - 05:48
Novavax’s Covid Vaccine Is Authorized in Europe
The vaccine will be the fifth to become available in the E.U., which already has ample supplies.
2022 forecast: With omicron extending the pandemic, how will biopharma respond to COVID?
2022 forecast: With omicron extending the pandemic, how will biopharma respond to COVID? kdunleavy Mon, 12/20/2021 - 21:28
Biogen Slashes Price of Alzheimer’s Drug Aduhelm, as It Faces Obstacles
A group of Alzheimer’s experts and health advocates called on the F.D.A. to withdraw its approval of the drug, the latest of several setbacks for the treatment.
Intra-Cellular scores another FDA nod for Caplyta, this time for bipolar disorder
Intra-Cellular scores another FDA nod for Caplyta, this time for bipolar disorder kdunleavy Mon, 12/20/2021 - 15:54
Editor’s corner: The year of vaccines for Fierce Pharma
Editor's corner: The year of vaccines for Fierce Pharma esagonowsky Mon, 12/20/2021 - 15:46
Bluebird bio hits FDA clinical hold—again—for gene therapy in sickle cell disease
Bluebird bio hits FDA clinical hold—again—for gene therapy in sickle cell disease aliu Mon, 12/20/2021 - 10:28
Amgen, AstraZeneca score FDA nod for blockbuster hopeful asthma drug Tezspire
Amgen, AstraZeneca score FDA nod for blockbuster hopeful asthma drug Tezspire kdunleavy Mon, 12/20/2021 - 10:25
Biogen halves Aduhelm’s price and plots cost cuts as Medicare decision on controversial Alzheimer’s drug nears
Biogen halves Aduhelm's price and plots cost cuts as Medicare decision on controversial Alzheimer's drug nears aliu Mon, 12/20/2021 - 09:00
Novo Nordisk’s weight loss drug Wegovy to run short amid contract manufacturer hiccup
Novo Nordisk's weight loss drug Wegovy to run short amid contract manufacturer hiccup fkansteiner Mon, 12/20/2021 - 08:50
After EMA recommendation, Novavax’s COVID-19 vaccine nears rollout in Europe
After EMA recommendation, Novavax's COVID-19 vaccine nears rollout in Europe fkansteiner Mon, 12/20/2021 - 07:54
Eli Lilly finds embarrassment main cause of underreporting of symptoms in ulcerative colitis
Eli Lilly finds embarrassment main cause of underreporting of symptoms in ulcerative colitis sharon.coey Mon, 12/20/2021 - 07:20
Eli Lilly finds embarrassment main cause of underreporting of symptoms in ulcerative colitis
Eli Lilly finds embarrassment main cause of underreporting of symptoms in ulcerative colitis sharon.coey Mon, 12/20/2021 - 07:20